The UK government has made an additional £175 million ($212 million) in funding available for its push to make the country a go-to location for clinical research, adding to £200 million promised in March to strengthen the national data infrastructure.
The new money has been announced to coincide with the publication of a new three-year strategic plan aimed at recovering the UK’s capacity to deliver research following the pandemic, increasing national capacity for clinical research, and improving access to clinical trials for NHS patients.